Georg Evers
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 9
- Oncology 23
- Lung Cancer Research Studies 7
- Cancer Immunotherapy and Biomarkers 6
- Peptidase Inhibition and Analysis 4
- CAR-T cell therapy research 4
- Co-authors
- Arik Bernard Schulze (23 shared papers)Michael Möhr (28 shared papers)L. H. Schmidt (15 shared papers)Wolfgang E. Berdel (14 shared papers)Christoph Schliemann (10 shared papers)Dennis Görlich (10 shared papers)Georg Lenz (15 shared papers)Annalen Bleckmann (15 shared papers)
- Journals
- Cancers (6 papers)Translational Lung Cancer Research (2 papers)Canadian Respiratory Journal (2 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Georg Evers
44 papers receiving 560 citations
Peers
Comparison fields: 5 of 75
- Oncology 190
- Neurology 94
- Pulmonary and Respiratory Medicine 186
- Hematology 58
- Genetics 55
Countries citing papers authored by Georg Evers
This map shows the geographic impact of Georg Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Evers more than expected).
Fields of papers citing papers by Georg Evers
This network shows the impact of papers produced by Georg Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Evers. The network helps show where Georg Evers may publish in the future.
Co-authors
The 25 scholars most cited alongside Georg Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 59 | |
| 2 | 2019 | 58 | |
| 3 | 2017 | 53 | |
| 4 | 2020 | 40 | |
| 5 | 2021 | 30 | |
| 6 | 2016 | 28 | |
| 7 | 2023 | 25 | |
| 8 | 2019 | 23 | |
| 9 | 2015 | 21 | |
| 10 | 2022 | 15 | |
| 11 | 2020 | 14 | |
| 12 | 2020 | 14 | |
| 13 | Normal values of immunoglobulins in premature and in full-term infants, calculated as percentiles. | 1975 | 14 |
| 14 | 2024 | 13 | |
| 15 | 2014 | 13 | |
| 16 | 2013 | 12 | |
| 17 | 2019 | 11 | |
| 18 | 2023 | 10 | |
| 19 | 2008 | 9 | |
| 20 | 2022 | 9 |
About Georg Evers
Georg Evers is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Neurology and Immunology, having authored 52 papers that have together received 573 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Research Studies (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Long-Term Effects of COVID-19 (5 papers), Acute Myeloid Leukemia Research (5 papers), Peptidase Inhibition and Analysis (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Oncology (190 citations), Neurology (94 citations), Pulmonary and Respiratory Medicine (186 citations), Hematology (58 citations) and Genetics (55 citations). Georg Evers has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Arik Bernard Schulze, Michael Möhr, L. H. Schmidt, Wolfgang E. Berdel, Christoph Schliemann, Dennis Görlich, Georg Lenz, Annalen Bleckmann, Alessandro Marra and Birthe Heitkötter. Their work appears in journals such as Cancers, Translational Lung Cancer Research, Canadian Respiratory Journal, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.